185 related articles for article (PubMed ID: 34161831)
1. Development and validation of a reporter gene assay for bioactivity determination of Anti-CGRP monoclonal antibodies.
Guo X; Yu C; Wang L; Zhang F; Wang K; Huang J; Wang J
Anal Biochem; 2021 Dec; 634():114291. PubMed ID: 34161831
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a reporter gene assay to determine the bioactivity of anti-CTLA-4 monoclonal antibodies.
Liu C; Yu C; Yang Y; Cui Y; Zhang F; Wang L; Wang J
Int Immunopharmacol; 2021 Dec; 101(Pt A):108277. PubMed ID: 34773758
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a reliable cell-based reporter gene assay for measuring bioactivities of therapeutic anti-interleukin-23 monoclonal antibodies.
Huang J; Wang L; Yu C; Fu Z; Liu C; Zhang H; Wang K; Guo X; Wang J
Int Immunopharmacol; 2020 Aug; 85():106647. PubMed ID: 32504997
[TBL] [Abstract][Full Text] [Related]
4. CGRP and Migraine: The Role of Blocking Calcitonin Gene-Related Peptide Ligand and Receptor in the Management of Migraine.
Maasumi K; Michael RL; Rapoport AM
Drugs; 2018 Jun; 78(9):913-928. PubMed ID: 29869205
[TBL] [Abstract][Full Text] [Related]
5. A robust reporter assay for the determination of the bioactivity of IL-4R-targeted therapeutic antibodies.
Yu X; Yu C; Wang K; Liu C; Wang L; Wang J
J Pharm Biomed Anal; 2021 May; 199():114033. PubMed ID: 33774455
[TBL] [Abstract][Full Text] [Related]
6. Calcitonin gene-related peptide (CGRP)-targeted therapies as preventive and acute treatments for migraine-The monoclonal antibodies and gepants.
Chiang CC; Schwedt TJ
Prog Brain Res; 2020; 255():143-170. PubMed ID: 33008505
[TBL] [Abstract][Full Text] [Related]
7. A new era for migraine: The role of calcitonin gene-related peptide in the trigeminovascular system.
Chen ST; Wu JW
Prog Brain Res; 2020; 255():123-142. PubMed ID: 33008504
[TBL] [Abstract][Full Text] [Related]
8. Antigens and Antibodies in Disease With Specifics About CGRP Immunology.
Taylor FR
Headache; 2018 Nov; 58 Suppl 3():230-237. PubMed ID: 30187471
[TBL] [Abstract][Full Text] [Related]
9. History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment.
Tepper SJ
Headache; 2018 Nov; 58 Suppl 3():238-275. PubMed ID: 30242830
[TBL] [Abstract][Full Text] [Related]
10. Effects of monoclonal antagonist antibodies on calcitonin gene-related peptide receptor function and trafficking.
Manoukian R; Sun H; Miller S; Shi D; Chan B; Xu C
J Headache Pain; 2019 Apr; 20(1):44. PubMed ID: 31039731
[TBL] [Abstract][Full Text] [Related]
11. Development of a robust reporter gene based assay for the bioactivity determination of IL-5-targeted therapeutic antibodies.
Fu Z; Yu C; Wang L; Gao K; Xu G; Wang W; Cao J; Wang J
J Pharm Biomed Anal; 2018 Jan; 148():280-287. PubMed ID: 29059618
[TBL] [Abstract][Full Text] [Related]
12. Targeting CGRP for the Prevention of Migraine and Cluster Headache: A Narrative Review.
Yuan H; Spare NM; Silberstein SD
Headache; 2019 Jul; 59 Suppl 2():20-32. PubMed ID: 31291020
[TBL] [Abstract][Full Text] [Related]
13. Anti-CGRP and anti-CGRP receptor monoclonal antibodies as antimigraine agents. Potential differences in safety profile postulated on a pathophysiological basis.
Tringali G; Navarra P
Peptides; 2019 Jun; 116():16-21. PubMed ID: 31018157
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies for migraine: preventing calcitonin gene-related peptide activity.
Bigal ME; Walter S
CNS Drugs; 2014 May; 28(5):389-99. PubMed ID: 24638916
[TBL] [Abstract][Full Text] [Related]
15. Targeting calcitonin gene-related peptide: a new era in migraine therapy.
Charles A; Pozo-Rosich P
Lancet; 2019 Nov; 394(10210):1765-1774. PubMed ID: 31668411
[TBL] [Abstract][Full Text] [Related]
16. Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine.
Berman G; Croop R; Kudrow D; Halverson P; Lovegren M; Thiry AC; Conway CM; Coric V; Lipton RB
Headache; 2020 Sep; 60(8):1734-1742. PubMed ID: 32799325
[TBL] [Abstract][Full Text] [Related]
17. Calcitonin gene-related peptide (CGRP): a new target for migraine.
Russo AF
Annu Rev Pharmacol Toxicol; 2015; 55():533-52. PubMed ID: 25340934
[TBL] [Abstract][Full Text] [Related]
18. Calcitonin gene-related peptide (CGRP) and migraine current understanding and state of development.
Bigal ME; Walter S; Rapoport AM
Headache; 2013 Sep; 53(8):1230-44. PubMed ID: 23848260
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic antibodies against CGRP or its receptor.
Bigal ME; Walter S; Rapoport AM
Br J Clin Pharmacol; 2015 Jun; 79(6):886-95. PubMed ID: 25614243
[TBL] [Abstract][Full Text] [Related]
20. Erenumab in the treatment of migraine.
Jain S; Yuan H; Spare N; Silberstein SD
Pain Manag; 2018 Nov; 8(6):415-426. PubMed ID: 30235976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
